Nektar Therapeutics (NKTR)
39.22
+2.58
(+7.04%)
USD |
NASDAQ |
Oct 20, 16:00
39.00
-0.22
(-0.56%)
After-Hours: 07:38
Nektar Therapeutics Gross Profit (TTM) : 53.90M for June 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 53.90M |
| March 31, 2026 | 54.88M |
| December 31, 2025 | 54.21M |
| September 30, 2025 | 53.79M |
| June 30, 2025 | 61.88M |
| March 31, 2025 | 64.67M |
| December 31, 2024 | 67.74M |
| September 30, 2024 | 63.14M |
| June 30, 2024 | 55.17M |
| March 31, 2024 | 54.92M |
| December 31, 2023 | 56.35M |
| September 30, 2023 | 55.54M |
| June 30, 2023 | 62.48M |
| March 31, 2023 | 65.45M |
| December 31, 2022 | 70.42M |
| September 30, 2022 | 73.48M |
| June 30, 2022 | 74.43M |
| March 31, 2022 | 78.63M |
| December 31, 2021 | 77.01M |
| September 30, 2021 | 77.30M |
| June 30, 2021 | 82.16M |
| March 31, 2021 | 104.57M |
| December 31, 2020 | 131.19M |
| September 30, 2020 | 139.92M |
| June 30, 2020 | 139.75M |
| Date | Value |
|---|---|
| March 31, 2020 | 114.97M |
| December 31, 2019 | 93.24M |
| September 30, 2019 | 97.74M |
| June 30, 2019 | 96.42M |
| March 31, 2019 | 1.160B |
| December 31, 2018 | 1.169B |
| September 30, 2018 | 1.222B |
| June 30, 2018 | 1.347B |
| March 31, 2018 | 291.34M |
| December 31, 2017 | 278.56M |
| September 30, 2017 | 223.70M |
| June 30, 2017 | 105.75M |
| March 31, 2017 | 103.81M |
| December 31, 2016 | 135.22M |
| September 30, 2016 | 135.38M |
| June 30, 2016 | 159.27M |
| March 31, 2016 | 146.34M |
| December 31, 2015 | 196.68M |
| September 30, 2015 | 178.93M |
| June 30, 2015 | 249.39M |
| March 31, 2015 | 260.67M |
| December 31, 2014 | 172.17M |
| September 30, 2014 | 181.11M |
| June 30, 2014 | 105.49M |
| March 31, 2014 | 110.93M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Eli Lilly & Co. | 66.44B |
| Inovio Pharmaceuticals, Inc. | -3.015M |
| Tonix Pharmaceuticals Holding Corp. | 22.27M |
| Capricor Therapeutics, Inc. | -2.095M |
| Kyntra Bio, Inc. | 0.076M |